Disclosures & Course Information
Biologic Therapy for Inflammatory Bowel Disease: A Comprehensive Nursing Guide
Clinical Pharmacology, Administration, and Patient Management
Incorporating 2025 AGA and ACG Clinical Practice Guidelines
Target Audience: Registered Nurses, GI/Endoscopy Nurses, Infusion Nurses, Advanced Practice Nurses
Release Date: February 2026 | Expiration Date: February 2029
Nevada State Board of Nursing Approved CE Provider (NV-14175)
The author and planning committee members have no relevant financial relationships with ineligible companies to disclose. All content has been reviewed for bias and clinical accuracy.
This continuing education activity has received no commercial support.
This educational activity includes discussion of the following off-label or investigational uses:
Infliximab biosimilars — some agents may be used interchangeably with reference products
Certolizumab pegol — approved for Crohn's disease, used off-label for certain fistulizing phenotypes